Dachaigh › Luchd-obrach › Lupin Research, Inc.
Lupin Research, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Lupin Research, Inc. 12 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 12. Tuarastal meadhanach a chaidh a thabhann: $120,000.
A bheil Lupin Research, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Lupin Research, Inc. 12 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 10 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Manager, R & D Analytical | 2 | $138,841 |
| Scientist II - Formulation | 1 | $91,283 |
| Scientist - Pharmaceutical Development | 1 | $93,000 |
| Associate Scientist | 1 | $67,470 |
| Associate Principal, Device Engineer | 1 | $180,775 |
| Sr. Commissioning Qualification & Validation Engineer | 1 | $115,000 |
| Scientist I | 1 | $110,000 |
| Sr. Manufacturing Engineer | 1 | $125,000 |
| Quality Assurance Analyst | 1 | $75,000 |
| Senior Scientist - Formulation | 1 | $131,591 |
| Director, R & D Analytical | 1 | $245,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $91,283 |
| FY2024 | 2 | $147,888 |
| FY2025 | 1 | $110,000 |
| FY2026 | 6 | $134,729 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Chemists5
- Natural Sciences Managers3
- Industrial Engineers2
- Mechanical Engineers1
- Quality Control Analysts1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Manager, R & D Analytical | $139,815 Ìre III | Coral Springs, FL | 10 Ògmh 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Director, R & D Analytical | $245,000 Ìre IV | Coral Springs, FL | 23 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Manager, R & D Analytical | $137,867 Ìre II | Coral Springs, FL | 21 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Senior Scientist - Formulation | $131,591 Ìre II | Coral Springs, FL | 18 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Quality Assurance Analyst | $75,000 Ìre III | Coral Springs, FL | 5 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Sr. Manufacturing Engineer | $125,000 Ìre III | Coral Springs, FL | 9 Dùbh 2025 | 29 Dùbh 2025 | Dearbhaichte |
| Scientist I | $110,000 Ìre II | Coral Springs, FL | 4 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Sr. Commissioning Qualification & Validation Engineer | $115,000 Ìre III | Coral Springs, FL | 7 Cèit 2024 | 20 Cèit 2024 | Dearbhaichte |
| Associate Principal, Device Engineer | $180,775 Ìre IV | Coral Springs, FL | 16 Gearr 2024 | 12 Gibl 2024 | Dearbhaichte |
| Scientist - Pharmaceutical Development | $93,000 Ìre II | Coral Springs, FL | 13 Màrt 2023 | 20 Màrt 2023 | Dearbhaichte |
| Associate Scientist | $67,470 Ìre III | Coral Springs, FL | 16 Màrt 2021 | 22 Gibl 2021 | Dearbhaichte, an uair sin air a tharraing air ais |
| Scientist II - Formulation | $91,283 Ìre IV | Coral Springs, FL | 2 Gearr 2021 | 15 Gearr 2021 | Dearbhaichte, an uair sin air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).